State of Wisconsin Investment Board
ARQT icon

State of Wisconsin Investment Board’s Arcutis Biotherapeutics ARQT Stock Holding History

State of Wisconsin Investment Board’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.38M Buy
100,902
+1,655
+2% +$42.2K 0.01% 1345
2025
Q4 		$2.88M Sell
99,247
-24,714
-20% -$633K 0.01% 1248
2025
Q3 		$2.34M Buy
123,961
+34,082
+38% +$538K 0.01% 1302
2025
Q2 		$1.26M Sell
89,879
-62,982
-41% -$883K ﹤0.01% 1491
2025
Q1 		$2.39M Buy
152,861
+43,130
+39% +$608K 0.01% 1181
2024
Q4 		$1.53M Buy
109,731
+3,464
+3% +$38K ﹤0.01% 1380
2024
Q3 		$988K Buy
106,267
+4,978
+5% +$49.1K ﹤0.01% 1569
2024
Q2 		$942K Buy
+101,289
New +$916K ﹤0.01% 1574
2023
Q4 		– Sell
-75,462
Closed -$401K – 2373
2023
Q3 		$401K Buy
75,462
+38,092
+102% +$324K ﹤0.01% 1919
2023
Q2 		$356K Sell
37,370
-2,001
-5% -$22.2K ﹤0.01% 1936
2023
Q1 		$433K Sell
39,371
-284
-0.7% -$4.11K ﹤0.01% 1934
2022
Q4 		$587K Sell
39,655
-2,426
-6% -$42.4K ﹤0.01% 1830
2022
Q3 		$804K Buy
42,081
+13,889
+49% +$315K ﹤0.01% 1665
2022
Q2 		$601K Buy
28,192
+2,892
+11% +$59.3K ﹤0.01% 1982
2022
Q1 		$487K Hold
25,300
– – ﹤0.01% 1928
2021
Q4 		$525K Hold
25,300
– – ﹤0.01% 1669
2021
Q3 		$604K Hold
25,300
– – ﹤0.01% 1633
2021
Q2 		$690K Hold
25,300
– – ﹤0.01% 1585
2021
Q1 		$732K Hold
25,300
– – ﹤0.01% 1457
2020
Q4 		$712K Buy
25,300
+9,300
+58% +$228K ﹤0.01% 1425
2020
Q3 		$469K Hold
16,000
– – ﹤0.01% 1505
2020
Q2 		$484K Hold
16,000
– – ﹤0.01% 1441
2020
Q1 		$477K Buy
+16,000
New +$430K ﹤0.01% 1364

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State of Wisconsin Investment Board's ARQT Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Arcutis Biotherapeutics (ARQT) stake by 1.7% in Q1 2026, buying an estimated $42.2K and bringing the position to 100,902 shares worth $2.38M. The position accounts for 0.01% of the portfolio, ranked #1345.

State of Wisconsin Investment Board first reported a position in ARQT in Q1 2020 and has held it in 23 quarters since. The position peaked at $2.88M in Q4 2025. 270 funds tracked by Wall St. Rank hold ARQT as of Q1 2026.

  • State of Wisconsin Investment Board held 100,902 shares of Arcutis Biotherapeutics worth $2.38M as of Q1 2026.
  • State of Wisconsin Investment Board bought 1,655 Arcutis Biotherapeutics shares in Q1 2026, an estimated $42.2K.
  • Arcutis Biotherapeutics made up 0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1345 holding.
  • State of Wisconsin Investment Board first reported a position in Arcutis Biotherapeutics in Q1 2020 and has held it in 23 quarters since.
  • State of Wisconsin Investment Board's Arcutis Biotherapeutics position peaked at $2.88M in Q4 2025.
  • 270 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.